Skip to content

Author

Huda Akram

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Hippo pathway in cancer ferroptosis: from mechanism insights to targeted therapies

Ferroptosis is an iron-dependent form of regulated cell death driven by membrane lipid peroxidation and has become an important therapeutic vulnerability in cancer. The Hippo pathway, through its transcriptional effectors Yes-associated protein and transcriptional coactivator with PDZ-binding motif, links cell contact,...

Zi-Yi Xu, Ruo-Chen Yang, Huda Akram et al. · 0 citations
Review Open access Sep 2026

Ferroptosis nanomedicine for cancer therapy: strategies and challenges

The biological rationale for ferroptosis-targeted cancer therapy is summarized, major translational barriers are analyzed, and nanomedicine strategies that may move ferroptosis induction from experimental proof of concept toward clinically interpretable intervention are synthesized.

Yan-Pin Ma, Zi-Yi Xu, Huda Akram et al. · 0 citations
Open access Sep 2026

Integrating single-cell transcriptomics to construct an oncogene-driven prognostic model and elucidate metabolic-immune crosstalk in hepatocellular carcinoma

The constructed RSF model offers a promising computational framework for risk stratification and provides hypothesis-generating insights that may inform future personalized treatment strategies for HCC patients, suggesting a profound link with single-cell metabolic‒immune crosstalk.

Zi-Ming Wang, Zi-Yi Xu, Ming-Hang Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.